Roachclip
New Member
The intensity in the medical marijuana debate continues to strengthen as organizations like Dads And Mad Moms Against Drug Dealers (DAMMADD) increase their actions urging legislators, medical and health professionals, and the public to find a scientific solution to the "medical" marijuana issue.
"If there are components of the marijuana plant that have true medical value, with today's technology we should be able to identify them and put them into a pharmaceutical product that is tested and safely administered like other prescription medicines," stated DAMMADD Founder Steven Steiner.
While pro-marijuana activists have and are promoting marijuana legalization using medical marijuana cigarettes, people like Vermont's Attorney General William Sorrell are continuing to stand firm by countering, "It is absolutely critical for consumers to understand that there is no such thing as a 'safe' cigarette." (5/18/04, Wall Street Journal) Further supporting his position, Dr. Nora Volkov, Director of the National Institute on Drug Abuse, recently testified before Congress saying, "Even if marijuana were found to have some medical property in the future, doctors could not in good faith recommend patients smoke it because it is inherently toxic as a delivery system. When considering new drug therapies, any positive effects must outweigh the negative side effects." (April, 2004)
One product, Sativex from GW Pharmaceutical, is available for research. This new marijuana-derived, standardized pharmaceutical product sprayed under the tongue - not smoked - appears to have potential as a medically-acceptable delivery system. If FDA approved, it could supplant crude, tar-laden marijuana cigarettes and provide suffering patients and their doctors access to a genuine medicine. Clinical data resulting from studies conducted in England in hundreds of patients over the past few years is promising.
DAMMADD founder, Steven Steiner, said, "Our government can counter the 'medicine by popular vote' trend by finding and
"If there are components of the marijuana plant that have true medical value, with today's technology we should be able to identify them and put them into a pharmaceutical product that is tested and safely administered like other prescription medicines," stated DAMMADD Founder Steven Steiner.
While pro-marijuana activists have and are promoting marijuana legalization using medical marijuana cigarettes, people like Vermont's Attorney General William Sorrell are continuing to stand firm by countering, "It is absolutely critical for consumers to understand that there is no such thing as a 'safe' cigarette." (5/18/04, Wall Street Journal) Further supporting his position, Dr. Nora Volkov, Director of the National Institute on Drug Abuse, recently testified before Congress saying, "Even if marijuana were found to have some medical property in the future, doctors could not in good faith recommend patients smoke it because it is inherently toxic as a delivery system. When considering new drug therapies, any positive effects must outweigh the negative side effects." (April, 2004)
One product, Sativex from GW Pharmaceutical, is available for research. This new marijuana-derived, standardized pharmaceutical product sprayed under the tongue - not smoked - appears to have potential as a medically-acceptable delivery system. If FDA approved, it could supplant crude, tar-laden marijuana cigarettes and provide suffering patients and their doctors access to a genuine medicine. Clinical data resulting from studies conducted in England in hundreds of patients over the past few years is promising.
DAMMADD founder, Steven Steiner, said, "Our government can counter the 'medicine by popular vote' trend by finding and
